University of Louisville
P

Polygenic Risk Scoring for Coronary Artery Disease

By University of Louisville FEATURING Pradeep Natarajan
By University of Louisville FEATURING Pradeep Natarajan
6 views
March 29, 2024
0 Comments
Login to view comments. Click here to Login

Featured Video

18:06
Lilly Obesity

Getting Patients Started with an Obesity Treatment Option for Adults

Feat. E. Lazarus

Featured Video

18:06
Lilly Obesity

Getting Patients Started with an Obesity Treatment Option for Adults

Feat. E. Lazarus

Related Content

AUTOPLAY
12:04
Stephen Kopecky

Role of PCSK9 Inhibitors in Diabetes

49:21
Physicians Committee for Responsible Medicine

Health of Vegetarians and Vegans: Findings From EPIC-Oxford and Othe…

Feat. T. J. Key
28:13
National Lipid Association

New Insights into Triglyceride Therapy and the Role of Omega-3 Fatty…

Feat. R. Mason
26:32
Practical Ways to Achieve Targets in Diabetes Care

Metabolic Surgery vs. Pharmacotherapy for Treatment of Obesity

Feat. S. Nissen
19:20
National Lipid Association

Colchicine: Now and What’s Next?

Feat. C. Ballantyne
22:14
Practical Ways to Achieve Targets in Diabetes Care

Role of Lipoprotein (a) in Coronary Disease: An Emerging Novel Target

Feat. S. Nissen
21:10
National Lipid Association

Plant-based Diets for Improving Lipids

Feat. K. Williams
11:26
Houston Methodist DeBakey Heart and Vascular Center

Aspirin for the Primary Prevention of Cardiovascular Disease: What C…

Feat. M. Miedema
11:50
American Heart & Vascular Institute

New Medications for Heart Failure: SGLT2 Inhibitors and Vericiguat. …

Feat. M. Kittleson
15:25
Javed Butler

SGLT2 Inhibitors and Heart Failure in Type-2 Diabetes Mellitus

29:04
15th Annual Orange County Symposium for Cardiovascular Disease Prevention

LDL-C: Earlier and Lower Is Better and Safer?

Feat. P. Rosenblit
49:59
Scripps Health

Pre-Operative Medical Evaluation Update

Feat. J. Diamant
14:52
Richard Pratley

Highlights From the 81st ADA Scientific Sessions: The AMPLITUDE Study

25:54
13th Orange County Symposium for Cardiovascular Disease Prevention

SGLT2 inhibitors and GLP-1 agonists: Why Are They Important and Whic…

Feat. Y. Handelsman
30:00
Piedmont Heart Institute

Cardiometabolic Therapies: GLP-1 RAs and SGLT-2i

Feat. J. Burkle
25:05
Heart, Diabetes and Kidney: Make the Link

Heart Failure, the Picture is Changing: Q&A Discussion

Feat. P. Seferovic, E. Standl, M. Ibrahim
11:17
Basem Mishriky

ADA 2022: Heart Failure Hospitalization Among Non-Hispanic Black Com…

62:17
HeartFlow

Chest Pain in Women: CT's role in making an accurate diagnosis

Feat. L. Shaw, M. Gulati
62:08
University of Louisville

Update on Coronary Revascularization

Feat. S. Ghafghazi
24:45
National Lipid Association

Cardiovascular Disease in Patients with HIV

Feat. W. R. Short